The Numbers Everyone's Avoiding

Let me say this directly: Maryland is losing its independent pharmacy backbone. Over the last three fiscal years, 156 pharmacies and distribution centers closed while only 97 opened. That's a net loss of 59 locations across a single state.

In zip code 21215, the Park Heights area of Baltimore, there were 6 closures. Six. In one neighborhood.

The data points to one culprit with such clarity that I'm honestly puzzled why legislative action has been so slow. PBM reimbursement practices are hollowing out independent pharmacy economics. The Big Three PBMs control 80 percent of the marketplace, and for years they've been paying less and less, while simultaneously charging more in DIR fees (Direct and Indirect Remuneration). Independent pharmacies are getting crushed in the middle.

Add to this the domino effect from Rite Aid's bankruptcy and CVS's decision to shutter hundreds of stores. The market is contracting, and independent pharmacies are absorbing the pressure.

But here's the deeper truth that I want us to say out loud together: these are not just business closures. These are healthcare access failures.

What Really Gets Lost When a Pharmacy Closes

When an independent pharmacy closes, it takes away something that chains fundamentally cannot replace: relationship, context, continuity of care.

The independent pharmacy knows that their patient takes three different medications for diabetes. They know the patient sometimes forgets which one is which, so the pharmacy colors the labels with stickers. They know a patient’s granddaughter has a tree nut allergy, and they flagged their prescriptions to make sure nothing the patient is taking contains tree nuts. When the pharmacist is filling a prescription, they spend time asking the patient questions. Not because they have to. Because they know them.

That's not sentimentality. That's clinical practice. Studies show that continuity of pharmacy care reduces medication errors, improves adherence, and catches dangerous drug interactions that get missed in systems where the pharmacist has never met the patient before.

When a pharmacy shutters its doors, the community doesn't just lose a business. It loses a healthcare access point in a neighborhood where three quarters of residents don't have reliable transportation. It loses the place where uninsured patients know they can get a good deal on generics. It loses the pharmacist who has built fifteen years of trust with the community.

And the data confirms this isn't abstract harm. Research from the National Association of Chain Drug Stores (NACDS) and independent pharmacy advocates shows that pharmacy deserts, areas underserved by pharmacy access, are correlated with worse medication adherence, more preventable hospitalizations, and delayed disease detection.

Maryland is creating pharmacy deserts. And the people paying the price are the ones who can least afford to lose a healthcare touchpoint.

Why Independents Survive What Chains Cannot

Here's the contrarian insight that keeps me awake: chains and independents are competing on the wrong metric. Chains compete on volume, location density, and automation. But they cannot compete on what independents do best: clinical depth, cultural trust, and personalization.

A chain pharmacy fills 300 prescriptions a shift. An independent pharmacy fills 100. But that independent pharmacy's 100 prescriptions carry more clinical value per transaction. The pharmacist knows the patient's entire medication history. They know about side effects the patient's been hiding from their doctor. They catch interactions that automated systems miss.

Chains cannot replicate this. Not because they don't want to. Because their economics don't allow it. When you're optimizing for throughput and inventory velocity, you can't afford to spend fifteen minutes with a patient understanding their barriers to adherence.

Independent pharmacies survive because they're practicing at the top of their license. The pharmacist is a clinician first, a medication dispenser second. The technician is not "just a tech" doing data entry. They're a care partner doing medication therapy management, immunization support, and patient education.

This is where innovation meets irreplaceability. And it's the foundation that surviving independents are doubling down on right now.

The Resilience Playbook for Independents in 2026

If you're running an independent pharmacy in Maryland or anywhere else, you cannot outcompete chains on their terms. You have to win on yours.

First: Diversify Your Sourcing

When margins are thin and you're watching other locations close, acquisition cost is a lever you can actually control. Most independents source almost exclusively from their primary wholesaler. This is a risk concentration problem.

Here's what the surviving independents are doing: they're building a diversified sourcing strategy. They're joining GPOs for better pricing on generic volume. They're negotiating direct contracts with manufacturers for drugs where they have specialty services (diabetes management, anticoagulation). And increasingly, they're turning to secondary sourcing and pharmacy-to-pharmacy marketplaces.

This is not about abandoning your primary wholesaler. It's about having strategic options. If a specific branded drug is going to run you below cost through your primary wholesaler, and you can source it from a secondary market at 8 percent discount off WAC, that's a 100 dollar margin decision on a single NDC that suddenly becomes workable.

RxPost's pharmacy-to-pharmacy marketplace is an example of this kind of strategic lever. Independents recovering an average of 60,800 dollars in sixty days from surplus inventory. Securing medications at 21.8 percent discount versus WAC. These aren't theoretical gains. They're survival mechanics for pharmacies that are paying attention.

Second: Anchor Your Business to Clinical Services

Chains have better prices on widgets. You have better relationships with patients. Use that.

Immunizations, medication therapy management, adherence coaching, chronic disease management services. These services generate revenue, deepen the patient relationship, and differentiate you from chains that treat you like you're just picking items off a shelf.

Start with the service that fits your pharmacist's expertise and your patient population. If you have an aging population, anticoagulation management might be your anchor. If you have high diabetes prevalence, diabetes care coaching. If you're in an immigrant community, language-accessible MTM.

Build the service, prove the clinical outcomes and revenue model, then expand.

Third: Become a Community Voice on the Closure Crisis

Maryland pharmacists are urging lawmakers to act. Legislative progress is slow, but the conversation is happening. Organizations like the National Community Pharmacists Association (NCPA) are leading advocacy efforts. Independents who are visible in this conversation, who are educating their communities about pharmacy access and healthcare equity, become indispensable.

Write a letter to your local newspaper. Speak at city council meetings. Partner with community health organizations to educate people about what independent pharmacy provides. Document the harm that closures create.

This is not just advocacy. It's market positioning. You're telling your community: I am not replaceable. I am not a chain. I am a local healthcare fixture that you cannot lose.

Fourth: Think Entrepreneurially About Your Pharmacy's Future

And here's the bigger frame: if you're running an independent pharmacy in 2026, you cannot think like a pharmacy owner from 1996. You have to think like an entrepreneur.

That means: understanding your unit economics deeply. Testing new service lines. Building a team that understands the business, not just the pharmacy operations. Finding strategic partnerships (with healthcare systems, employers, clinical programs) that bring volume and relevance.

The Closure Crisis Is a Signal

Maryland's pharmacy closures aren't just a Maryland problem. They're a national trend. Nearly 1 in 3 retail pharmacies have closed since 2010. Rite Aid (R.I.P.), Walgreens, CVS are all contracting, while independent pharmacies have stabilized. But the market is consolidating.

But here's what I know from talking to independents who are thriving, even now: they're not nostalgic. They're not waiting for legislative rescue. They're being smart about margins, bold about services, and clear about their irreplaceable value.

The closure crisis is a signal. It's telling us that business as usual doesn't work anymore. But it's also telling us that independents who practice at the top of their license, who are embedded in their communities, who think like entrepreneurs, are exactly what healthcare needs.

Take Action This Week

If you're an independent pharmacy owner: Conduct a sourcing audit. Document your acquisition costs for 20 key medications across your primary wholesaler. Research one alternative sourcing option (GPO, secondary marketplace, or direct manufacturer contract). Calculate the margin impact. This week.

If you're part of an independent pharmacy team: Talk to your manager about one clinical service you could help launch. Start small. Start with what you already know how to do.

If you're in a community losing pharmacies: Write a letter to your pharmacist or reach out to the NCPA. Let them know what you stand to lose. These stories matter in the legislative conversation.